GREENFIELD, Ind., Oct. 1, 2008 - Elanco, a division of Eli Lilly and Company, announced today it has finalized the purchase of Posilac (sometribove), a supplement for dairy cows, from Monsanto. The acquisition includes complete worldwide rights, a state-of-the-art manufacturing facility in Augusta, Ga., and product-support operations. Elanco says the move underscores its commitment to helping farmers produce an abundant supply of safe, nutritious, affordable food.
“Our entire Elanco dairy team is thrilled to be the steward of this vital technology, and already is hard at work to make this business transition seamless for the dairy producers who use Posilac,” said Roy Riggs, director of Elanco’s dairy business unit. “Importantly, with this acquisition, Elanco is strongly committed to collaborating with and providing choice to the total dairy food chain.”
Producers can continue to work directly with their Posilac representatives for product support and inquiries. The same convenient toll-free number - (800) 233-2999 - will remain available for placing orders and asking additional questions. Producers using other Elanco products in their herd-health programs may continue to buy those items from their current animal-health suppliers.
The integration of Posilac into Elanco’s dairy business also will bring together a team of professionals who specialize in improving production efficiencies.
Elanco Completes Acquisition of Posilac
October 1, 2008